A pathogen reduction clinical trial in retrospect.
作者信息
Rebulla Paolo
机构信息
Blood Transfusion Service, Foundation Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
出版信息
Blood Transfus. 2017 Jul;15(4):329-332. doi: 10.2450/2017.0340-16. Epub 2017 Apr 10.
Abstract
摘要
相似文献
1
A pathogen reduction clinical trial in retrospect.一项病原体灭活临床试验的回顾
Blood Transfus. 2017 Jul;15(4):329-332. doi: 10.2450/2017.0340-16. Epub 2017 Apr 10.
2
Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasma.托斯卡纳输血系统关于适当使用溶剂/去污剂灭活新鲜冰冻血浆的建议。
Blood Transfus. 2008 Jan;6(1):25-36. doi: 10.2450/2008.0027-07.
3
Pathogen inactivation treatment of plasma and platelet concentrates and their predicted functionality in massive transfusion protocols.血浆和血小板浓缩物的病原体灭活处理及其在大量输血方案中的预测功能。
Transfusion. 2017 May;57(5):1208-1217. doi: 10.1111/trf.14043. Epub 2017 Feb 24.
4
The six questions of pathogen reduction technology: an overview of current opinions.病原体灭活技术的六个问题：当前观点概述
Transfus Apher Sci. 2008 Aug;39(1):51-7. doi: 10.1016/j.transci.2008.05.007. Epub 2008 Jul 9.
5
Pathogen reduction technology.
Transfus Apher Sci. 2008 Aug;39(1):1. doi: 10.1016/j.transci.2008.06.001. Epub 2008 Jul 10.
6
Current opinions on the role of pathogen reduction technology in improving the viral safety of blood and derivatives.
Transfus Apher Sci. 2008 Aug;39(1):49-50. doi: 10.1016/j.transci.2008.05.008. Epub 2008 Jul 9.
7
Advances in transfusion medicine: gastrointestinal bleeding.输血医学进展：胃肠道出血
Transfus Med. 2018 Apr;28(2):132-139. doi: 10.1111/tme.12446. Epub 2017 Jul 24.
8
Current methods for the reduction of blood-borne pathogens: a comprehensive literature review.当前减少血源性病原体的方法：一项全面的文献综述。
Blood Transfus. 2013 Jul;11(3):343-8. doi: 10.2450/2013.0218-12. Epub 2013 Mar 14.
9
Massive transfusions for critical bleeding: is everything old new again?用于严重出血的大量输血：一切旧貌换新颜了吗？
Transfus Med. 2018 Apr;28(2):140-149. doi: 10.1111/tme.12524. Epub 2018 Apr 1.
10
Blood component therapy.血液成分疗法
Indian J Pediatr. 2008 Jul;75(7):717-22. doi: 10.1007/s12098-008-0136-0. Epub 2008 Aug 21.
引用本文的文献
1
Economic Analyses of Pathogen-Reduction Technologies in Blood Transfusion: A Systematic Literature Review.经济分析在输血病原体减少技术：系统文献回顾。
Appl Health Econ Health Policy. 2021 Jul;19(4):487-499. doi: 10.1007/s40258-020-00612-6. Epub 2021 Feb 8.
2
Budget impact of implementing platelet pathogen reduction into the Italian blood transfusion system.血小板病原体减少技术在意大利输血系统中的实施预算影响。
Blood Transfus. 2018 Nov;16(6):483-489. doi: 10.2450/2018.0115-18. Epub 2018 Sep 3.
本文引用的文献
1
Clinical effectiveness of platelets in additive solution treated with two commercial pathogen-reduction technologies.两种商业性病原体灭活技术处理的添加溶液中血小板的临床有效性。
Transfusion. 2017 May;57(5):1171-1183. doi: 10.1111/trf.14042. Epub 2017 Feb 24.
2
Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis.血液系统恶性肿瘤患者的出血风险及血小板输注的使用：复发事件分析
Haematologica. 2015 Jun;100(6):740-7. doi: 10.3324/haematol.2014.118075. Epub 2015 Mar 20.
3
A no-prophylaxis platelet-transfusion strategy for hematologic cancers.无预防性血小板输注策略用于血液系统恶性肿瘤。
N Engl J Med. 2013 May 9;368(19):1771-80. doi: 10.1056/NEJMoa1212772.
4
Clinical trials evaluating pathogen-reduced platelet products: methodologic issues and recommendations.评价病原体减少血小板产品的临床试验：方法学问题与建议。
Transfusion. 2013 Aug;53(8):1843-55. doi: 10.1111/j.1537-2995.2012.03951.x. Epub 2012 Nov 12.
5
Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.治疗性血小板输注与血液病患者常规预防性血小板输注的比较：一项开放标签、多中心、随机研究。
Lancet. 2012 Oct 13;380(9850):1309-16. doi: 10.1016/S0140-6736(12)60689-8. Epub 2012 Aug 8.
6
Dose of prophylactic platelet transfusions and prevention of hemorrhage.预防性血小板输血剂量与出血预防。
N Engl J Med. 2010 Feb 18;362(7):600-13. doi: 10.1056/NEJMoa0904084.
7
Improving the reporting of pragmatic trials: an extension of the CONSORT statement.改善实用性试验的报告：CONSORT声明的扩展
BMJ. 2008 Nov 11;337:a2390. doi: 10.1136/bmj.a2390.
8
Methods for the analysis of bleeding outcomes in randomized trials of PLT transfusion triggers.血小板输注触发因素随机试验中出血结局的分析方法
Transfusion. 2004 Aug;44(8):1135-42. doi: 10.1111/j.1537-2995.2004.03231.x.
9
The costs of conducting clinical research.开展临床研究的成本。
J Clin Oncol. 2003 Nov 15;21(22):4145-50. doi: 10.1200/JCO.2003.08.156. Epub 2003 Oct 14.
Zotero 插件